Publications

phase i dose-escalation study of tirapazamine chemoembolization for unresectable early- and intermediate-stage hepatocellular carcinoma

phase i trial on arterial embolization with hypoxia activated tirapazamine for unresectable hepatocellular carcinoma

liver metastasis restrains immunotherapy efficacy via macrophage-mediated t cell elimination